TREM2 and metabolic dysfunction-associated steatohepatitis: The liver tissue obtained from the MASH patient group and the control group with hepatic hemangioma, which is known not to have been diagnosed with MASH, shows that the upregulation of TREM2 in MASH patients is associated with hepatic steatosis and inflammation.